1. Home
  2. ELVN vs FARO Comparison

ELVN vs FARO Comparison

Compare ELVN & FARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FARO
  • Stock Information
  • Founded
  • ELVN 2016
  • FARO 1981
  • Country
  • ELVN United States
  • FARO United States
  • Employees
  • ELVN N/A
  • FARO N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FARO Industrial Machinery/Components
  • Sector
  • ELVN Health Care
  • FARO Industrials
  • Exchange
  • ELVN Nasdaq
  • FARO Nasdaq
  • Market Cap
  • ELVN 927.8M
  • FARO 819.6M
  • IPO Year
  • ELVN 2020
  • FARO 1997
  • Fundamental
  • Price
  • ELVN $21.30
  • FARO $43.72
  • Analyst Decision
  • ELVN Strong Buy
  • FARO Buy
  • Analyst Count
  • ELVN 5
  • FARO 2
  • Target Price
  • ELVN $39.60
  • FARO $35.50
  • AVG Volume (30 Days)
  • ELVN 594.3K
  • FARO 749.2K
  • Earning Date
  • ELVN 08-12-2025
  • FARO 08-07-2025
  • Dividend Yield
  • ELVN N/A
  • FARO N/A
  • EPS Growth
  • ELVN N/A
  • FARO N/A
  • EPS
  • ELVN N/A
  • FARO N/A
  • Revenue
  • ELVN N/A
  • FARO $341,046,000.00
  • Revenue This Year
  • ELVN N/A
  • FARO $3.49
  • Revenue Next Year
  • ELVN N/A
  • FARO $5.72
  • P/E Ratio
  • ELVN N/A
  • FARO N/A
  • Revenue Growth
  • ELVN N/A
  • FARO N/A
  • 52 Week Low
  • ELVN $13.30
  • FARO $13.52
  • 52 Week High
  • ELVN $30.03
  • FARO $43.90
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 55.53
  • FARO 80.93
  • Support Level
  • ELVN $18.53
  • FARO $42.33
  • Resistance Level
  • ELVN $24.11
  • FARO $43.90
  • Average True Range (ATR)
  • ELVN 1.96
  • FARO 0.26
  • MACD
  • ELVN 0.15
  • FARO -0.27
  • Stochastic Oscillator
  • ELVN 55.68
  • FARO 88.96

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FARO FARO Technologies Inc.

Faro Technologies Inc is a technology company. It designs, develops, manufactures, markets and supports software-driven, three-dimensional (3-D) measurement, imaging, and realization solutions for the 3D metrology, architecture, engineering and construction (AEC), Operations and Maintenance (O&M) and public safety analytics markets. The company enables its customers to capture, measure, manipulate, interact with and share 3D and 2D data from the physical world in a virtual environment and then translate the information back into the physical domain. FARO suite of 3D products and software solutions are used for the inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volumes or structures in 3D, surveying, and construction.

Share on Social Networks: